Zobrazeno 1 - 10
of 162
pro vyhledávání: '"R.V. Iaffaioli"'
Autor:
C. Coppola, Giovanna Piscopo, R.V. Iaffaioli, Gennaro Riccio, C. De Lorenzo, Carlo Maurea, A. Rienzo, Nicola Maurea, Antonio Barbieri
Publikováno v:
Annals of Oncology. 27:vi7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7aa25aefef3ecda9c5e2eb60745fb57b
https://doi.org/10.1093/annonc/mdw362.25
https://doi.org/10.1093/annonc/mdw362.25
Autor:
C. Coppola, C. De Lorenzo, Nicola Maurea, A. Rienzo, Giovanna Piscopo, Carlo Maurea, Antonio Barbieri, R.V. Iaffaioli, Gennaro Riccio
Publikováno v:
Annals of Oncology. 27:vi6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::196b0ce29d13cabe1c16f1a80c56d6dc
https://doi.org/10.1093/annonc/mdw362.24
https://doi.org/10.1093/annonc/mdw362.24
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C. Coppola, R.V. Iaffaioli, F. Galletta, Claudio Arra, D.W. Rea, Nicola Maurea, Giovanna Piscopo, C. Maurea
Publikováno v:
Annals of Oncology. 25:iv56
Aim: Anthracyclines are first line drugs against cancer, but produce a well-known cardiomyopathy through multiple mechanisms, which also include, among many, Ca2+ overload due to reduced SERCA2a activity and inappropriate opening of the RyR2, and imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef71c7d721caf4e787c5ca78603c04b6
https://doi.org/10.1093/annonc/mdu325.16
https://doi.org/10.1093/annonc/mdu325.16
Autor:
D.W. Rea, C. Maurea, Immacolata Capasso, F. Galletta, R.V. Iaffaioli, C. Coppola, Claudio Arra, Nicola Maurea, Giovanna Piscopo
Publikováno v:
Annals of Oncology. 25:iv56
Aim: ErbB2 is overexpressed in about 25% of breast cancers. It modulates myocardial development and function in the heart. Trastuzumab (T), an anti-ErbB2 inhibitor, has improved the prognosis of patients with breast cancer, but is related to an incre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84b6145d6d19241b1317daa8f3858cde
https://doi.org/10.1093/annonc/mdu325.15
https://doi.org/10.1093/annonc/mdu325.15
Autor:
E. Soumaka, R. J. Gil, A. I. Gziut, Ketil Grong, Claudio Arra, C. Rapti, G. Monti, Antonio Cittadini, C. Coppola, Chantal Dedobbeleer, C. G. Tocchetti, G. Deboeck, S. Psaras, P. Panagopoulou, C. H. Davos, A. Pawlak, M. Brudek, Y. Capetanaki, Nicola Maurea, Pirjo-Riitta Salminen, M. Mavroeidis, Knut Matre, Giuseppe De Palma, Ana Varela, G. Ragone, C. De Lorenzo, M. Lamotte, R.V. Iaffaioli, Robert Naeije, Philippe Unger, Christian Arvei Moen
Publikováno v:
European Journal of Echocardiography. 11:ii3-ii4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::297f823b9cfee9cf7bc193137e097306
https://doi.org/10.1093/ejechocard/jeq132
https://doi.org/10.1093/ejechocard/jeq132
Autor:
Gerolama Condorelli, Antonio Barbieri, Claudio Arra, C. Coppola, Giovanna Piscopo, Cristina Quintavalle, R.V. Iaffaioli, Nicola Maurea, C. G. Tocchetti, D.W. Rea
Publikováno v:
Publons
Background Doxorubicin (DOX) produces a well-known cardiomyopathy through multiple mechanisms, which include, among many, Ca2+ overload due to reduced SERCA2a activity and inappropriate opening of the RyR2, and impaired myocardial energetics. DOX gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46e71618403dac2ad5ce9f8da4952f4e
https://doi.org/10.1016/s0923-7534(20)34228-9
https://doi.org/10.1016/s0923-7534(20)34228-9
Publikováno v:
Gynecologic oncology. 52(2)
Forty-five ovarian cancer patients were submitted to abdominopelvic computed tomography after intraperitoneal administration of soluble contrast in large fluid volumes (3 liters of normal saline) (IPC-CT), for a total of 66 exams. In all cases standa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8329da64f521d8873e27734ae2c3f135
https://pubmed.ncbi.nlm.nih.gov/8314131
https://pubmed.ncbi.nlm.nih.gov/8314131
Autor:
C. De Lorenzo, Marianna Gala, Claudio Arra, Nicola Maurea, C. Coppola, Giuseppe De Palma, C. G. Tocchetti, D.W. Rea, G. Ragone, R.V. Iaffaioli, Antonio Luciano, Antonio Barbieri
Publikováno v:
Journal of Clinical Oncology. 29:e11040-e11040
e11040 Background: Anti-ErbB2 therapies are associated with increased risk of left ventricular (LV) dysfunction. Trastuzumab increases the frequency of asymptomatic decrease in LV ejection fraction (LVEF) by 3-18%, and the risk of heart failure (HF)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b00db312626c46a2dabec093b333b115
https://doi.org/10.1200/jco.2011.29.15_suppl.e11040
https://doi.org/10.1200/jco.2011.29.15_suppl.e11040
Autor:
Antonio Luciano, Nicola Maurea, Marianna Gala, G. Ragone, C. G. Tocchetti, D.W. Rea, Antonio Barbieri, Giuseppe De Palma, C. Coppola, Claudio Arra, R.V. Iaffaioli
Publikováno v:
Journal of Clinical Oncology. 29:e13612-e13612
e13612 Background: The mTOR inhibitor temsirolimus is being evaluated for anticancer efficacy in hundreds of clinical trials and is approved for treatment of advanced renal cell carcinoma. The PI3K...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::420277572dc9c7f0ae238fd195023957
https://doi.org/10.1200/jco.2011.29.15_suppl.e13612
https://doi.org/10.1200/jco.2011.29.15_suppl.e13612